DMCCB Basel Symposium 2027 is a specialized Swiss scientific conference dedicated to medicinal chemistry, chemical biology, and innovative approaches to drug discovery. Organized by the Swiss Chemical Society’s Division of Medicinal Chemistry and Chemical Biology, the symposium brings together scientists, researchers, industry professionals, academics, and students working at the intersection of chemistry, biology, and pharmaceutical research.

The event provides a platform for presenting the latest scientific developments and encouraging collaboration between fundamental research, applied science, academia, biotechnology, and the pharmaceutical industry. The 2027 edition will continue the symposium’s tradition of addressing cutting-edge topics in medicinal chemistry and chemical biology.

Key areas include drug discovery, medicinal chemistry, chemical biology, molecular design, therapeutic innovation, screening technologies, biological targets, chemical probes, pharmaceutical research, biotechnology, and translational science. Participants can exchange ideas, discover emerging research, and build connections across scientific disciplines.

The DMCCB Basel Symposium 2027 offers an important networking and knowledge-sharing opportunity for professionals and students interested in the development of new medicines and the application of modern chemical and biological approaches to therapeutic challenges.